| Market Cap | ₹247Cr |
| ROE | 7.16% |
| P/E Ratio(TTM) | 19.28 |
| EPS(TTM) | 1.67 |
| P/B Ratio | 1.76 |
| Dividend Yield | 0.00% |
| Industry P/E | 35.00 |
| Book Value | 18.27 |
| Debt to Equity | 0.36 |
| Face Value | 10 |
| Parent Organisation | Ambalal Sarabhai Enterprises Limited |
| Managing Director | NA |
| BSE Symbol | 500009 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 90.55 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.99 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.88 | ||
| Wockhardt | NA (0.00%) | -140.79 |